Exosomal delivery was also used to deliver microRNA to breast cancer cells expressing epidermal growth factor receptor (EGFR).141 Donor cells were transfected with a plasmid to express a fusion of the transmembrane domain of platelet-derived growth factor receptor (PDGF-R) and the GE11 peptide, which binds to EGFR. Here, EGFR is linked to breast carcinoma.